|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||2.46 / 5.99|
We bulked up on Abraxas Petroleum and Yamana Gold on weakness, as the markets pulled back and investors positioned for next week’s FOMC meeting.
Gold stocks remain an important component in your investment portfolios. Here's guidance on where to buy gold stocks on weakness.
We booked some profits in Huntington Bancshares and Builders FirstSource, while markets digested the likelihood of a March rate hike.
Gold prices are likely to stabilize this year, creating a new foundation for higher prices.
We opened a new position in Abraxas Petroleum on its above-average growth potential, as stocks faced selling pressure this week.
Yamana Gold's stock rating was lowered at Bank of America/Merrilly Lynch.
Set to report tonight, AUY has already pre-announced solid production results for the fourth quarter.
We closed out our position in OraSure Technologies for an average gain of 105% gain.
We used some of the proceeds to boost our stake in Jive Software this week. In addition, we initiated a position in drug-delivery system developer, Antares Pharma.
We used a price decline to add to our position in TherapeuticsMD this week.
We’d look to purchase Builders FirstSource, Jive Software and TherapeuticsMD on near-term declines.
We would consider adding to TherapeuticsMD on the next market decline and booking profits in ON Semiconductor into a rally.
A study of analyst recommendations at the major brokerages shows that Yamana Gold Inc is the #29 broker analyst pick, on average, out of the 50 stocks making up the Metals Channel Global Mining Titans Index, according to Metals Channel. The Metals Channel Global Mining Titans Index is comprised of the top fifty global leaders from the metals and mining sector.
We didn't trade in the model portfolio this week, but several of our holdings made big moves so far this year.
Despite recent downside volatility, investing in gold stocks remains an important component of portfolios in 2017.
We closed out a number of holdings for big gains in 2016, including McDermott, Cott and CECO Environmental.
The stock has moved higher 4 straight days and remains an attractive hedge against other portfolio holdings.
We didn't make any trades this week but are keeping 40% of the portfolio in cash to add names as opportunities arise.
Today is the last day for Yamana Gold investors to exercise purchase rights to acquire shares of Brio -- we'll let ours' expire.
We bought more TherapeuticsMD and Yamana Gold using proceeds from the sale of some Orasure shares.
We continue to favor AUY as a natural hedge against volatility in the broader market.
We bought shares of TherapeuticsMD but still have a large portion of the portfolio in cash.
Gold stocks remain in bull market territory since their recent lows, but a developing bear market provides a buying opportunity.